Revolutionizing translational potential in preclinical research
PhoenixBio Co., Ltd. (Headquarters, Japan)
This is our largest site with 70+ employees and a continuous production of 100+ PXB-mice per week. In addition to in vivo study services for NAFLD/NASH, viral hepatitis, gene-based therapeutics, DMPK/toxicology, and custom transplantations, we also offer HBV study services at this location.
PhoenixBio USA Corporation (NYC Office)
This office is responsible for all non-Japanese clients. We complete project management, marketing, and sales from this office.
CMHL Consortium (Non-profitable Organization)
The Chimeric Mouse with a Humanized Liver (CMHL) Consortium was started by PhoenixBio to work with pharmaceutical industry and academic leaders to enhance applications and translational research using the PXB-mouse model. As of 2021, a total of 11 institutions, including eight pharmaceutical companies, are participating in the research.